Summary.-Patients with acute lymphatic leukaemia (ALL) could be divided into two groups at diagnosis-those whose peripheral blood and/or bone marrow exhibited in vitro colony formation and those in whom it did not, but this finding did not appear to correlate with any clinical or haematological parameter, or with prognosis. The colony-forming potential of patients with ALL in their first full remission, early relapse or second remission did not deviate significantly from previously established normal values, but the colony-forming potential of patients in early remission was very significantly reduced. No loss of colony-forming potential of normal marrow cells was noted when they were cultured with cells from patients with ALL.
WHILE acute leukaemia in children is usually a disease of lymphatic origin, its nature is such that granulopoiesis is frequently compromised. Since the recovery and maintenance of granulocyte number and function is central to the achievement and maintenance of remission, the study of granulocyte precursors is relevant in ALL. One method for the assessment of granulocytic potential is the in vitro agar colony-forming cell (CFC) assay, in which colonies of granulocytes and macrophages may be grown from their common precursor cell (the CFC).
We have studied a total of 43 patients at various stages of their illness, bone marrow samples being taken only when these were indicated under the appropriate treatment protocol or as part of the general management of the patient. We have attempted to answer two basic questions:
(1) Certain prognostic factors are recognized in ALL, such as age, peripheral blood leucocyte count and mediastinal involvement, but they give only a crude guide to prognosis. Could the assessment of colony-forming potential or other features of colony growth help to distinguish patients with good or poor prognosis? (2) What variations may be detected by the in vitro CFC assay during the various stages of the disease?
MATERIALS AND METHODS
Patients with leukaemia. Forty-three patients with acute lymphatic leukaemia were studied. Diagnosis was based on clinical and morphological grounds and, with the exception of 4 adults, all were accepted into the MRC CONCORD or UKALL trials (Medical Research Council Working Party, 1973) and treated according to the allocated protocol. The criteria for the diagnosis of remission and relapse were in accordance with the appropriate trial.
Collection of samples-Samples of iliac crest marrow were aspirated under ketamine anaesthesia (local anaesthesia in older patients) and placed in bottles containing 5 ml collecting medium (BHK Eagle's from Wellcome Reagents Ltd) supplemented with 10% foetal calf serum (Flow Laboratories Ltd) and 10% trypticase soy broth (Difco), with 100 i.u. preservative-free heparin (Weddel Pharmaceuticals Ltd, London). Excess erythrocytes wNere removed by layering these samples over methyl-cellulose/triosil (Hullinger and Blaztiovec, 1967) and allowing them to sediment at room temperature for 30-50 min. The leucocyte-rich upper layer was collected, the leucocytes washed once, resuspended in collecting medium and a nucleated-cell count performed.
Peripheral blood samples from the patients were collected in preservative-free heparin and leucocyte suspensions prepared by allowing the blood to sediment and removing the leucocyte-rich supernatant plasma, the cells were concentrated by centrifugation, washed twice and resuspended in collecting medium and a nucleated-cell count performed prior to culture.
Culture technique.-All cultures were performed by the double-layer technique in Nunclon 30-mm plastic dishes (A/S Nunc, Denmark) using the modified Eagle's medium previously described (McNeill, 1971) . CS factor w%Nas provided by the inclusion of 5%0 (v/v) of human spleen or human embryo cellconditioned medium (Bradley and Sumner, 1968) in the Eagle's 1200 agar underlayer, this being the optimum concentration for colony growth of normal human marrow, as determined by previous titration. Eagle's 0.3%o agar medium was held at 37TC, cells added to the concentration required and 1-ml aliquots placed upon the gelled underlayers. All cell suspensions were cultured in quadruplicate. Cultures were incubated for 7 days at 37°C in sealed boxes containing 10% CO2 in humidified air, and colonies (aggregates of > 20 cells) counted with a stereoscopic microscope at x 40 magnification; the figures shown for colony counts are the mean of the 4 replicate cultures.
Co-culhire procedure
Normal bone marrow cells for co-culture were obtained from segments of rib removed at thoracotomy from patients in whom no haematological abnormality was present. The rib segments were placed in collecting medium and the cells suspended in this medium by washing through the medullary eavity with a Sahli marrow aspiration needle attached to a syringe.
The normal and leukaemic samples for co-culture were cultured separately at cell concentrations of 1, 2, 3 and 4 x 105 cells per ml respectively. Co-cultures were performed so that the total number of cells per ml was kept constant at 5 x 105 providing cultures with ratios of 1 : 4, 2 :3, 3 :2 and 4 :1 of the two cell populations being co-cultured. Where insufficient cells were available, all cell concentrations were halved, giving a total cell concentration of 2-5 x 105 per ml.
Plan of study
Samples were obtained from patients at 6 distinct phases of their illness. These were:
(i) At diagnosis. (ii) During early remission, i.e., leukaemic cells absent from peripheral blood and bone marrow, and before the start of prophylactic CNS irradiation (usually Week 4-6).
(iii) During full remission, i.e., once cyclical maintenance therapy commenced. As many as 12 samples were obtained from some of the patients with prolonged remissions. In order to prevent statistical bias from the inclusion of a large number of results from one or two patients, the samples were arranged in subgroups for analysis, each subgroup containing only one sample from each patient. When a second sample had been cultured, this was entered into the second subgroup, and so on to the 12th subgroup. As samples from patients in remission were normally taken at 12-weekly intervals, the latter subgroups clearly contain the patients with prolonged remissions. (iv) During the course of prophylactic CNS irradiation. (v) Early relapse. These were patients in their first remission in whom bone marrow aspiration revealed an increase in blast cells.
(vi) Patients in second remission.
Statistical methods
Tests of normality (Snedecor and Cochran, 1968) showed that the square roots of the colony counts were alwaIys normally distributed, although the untransformed data were not always so. The square roots of the colony counts were therefore used for comparison of the mean colony counts (and t tests) and for tests of correlation. (Morris, McNeill and Bridges, 1975) . Colony growth in remission and relapse (a) Early remission.-Marrow samples were obtained from 23 patients, usually during the fourth week of treatment, and admitted to this group if the proportion of blast cells was < 5 %. The mean colony count of the group was compared to that of normal marrow samples previously described (Morris et al., 1974) and it can be seen in Table III that the mean colony count of the patients in early remission was significantly lower than that of normal marrow (P < 0-00 1 at all cell concentrations tested). 
DISCUSSION
The growth of myeloid colonies from bone marrow and peripheral blood of some patients with ALL confirms the findings of other workers (Mack, Robinson and Holton, 1972; Moore et al., 1974; Ragab, Gilkerson and Myers, 1974) . We were unable to distinguish between patients who showed colony growth and those who did not on any other clinical or haematological grounds, and this feature did not have any noticeable prognostic significance While there are many reports of normal or raised colony formation in patients with acute leukaemia in remission, there are few serial follow-up studies. Ragab et al. (1974) cultured 129 marrow samples from a total of 62 children with ALL in complete remission over a 9-month period, and found they had a significantly lower colony-forming potential than 17 controls, but were still significantly higher than patients at diagnosis or relapse. Although their data were compared by the Wilcoxon rank sum test, it did not make allowances for replicate samples affecting the analysis. The reduction in colony-forming potential which they show for all patients in remission may be due to the fact that they have not segregated results from patients in early remission, particularly as marrow aspirations were performed every 4 weeks initially. However they did note in 3 out of 7 marrows taken one week after commencing therapy, when the blast cell count had fallen to < 5%, that there was no rise in colony-forming potential. In the present study, marrow samples taken at 4-6 weeks after the initiation oftherapy, at which time there was good recovery of normal cellularity, the colony-forming potential was still significantly reduced. (Testa and Lajtha, 1973) .
We conclude, therefore, that the answers to the questions which we set out to investigate are:
(1) That myeloid colony-forming potential at the time of diagnosis or relapse was not of value in determining the prognosis in patients with ALL, either to define those who would have a short remission or long survival.
(2) That apart from a lower colonyforming potential in early remission, no significant variations from normal were detectable at several other stages of the disease.
